Cannabis

Aurora Cannabis to enter U.S. market with $40 million of acquisition of CBD brand Reliva

By Staff The Canadian Press

Posted May 20, 2020 7:51 pm

Updated May 20, 2020 7:52 pm

1 min read

If you get Global News from Instagram or Facebook - that will be changing. Find out how you can still connect with us.

This article is more than 3 years old and some information may not be up to date.

Cannabis seedlings are shown at the new Aurora Cannabis facilty, Friday, November 24, 2017 in Montreal. THE CANADIAN PRESS/Ryan Remiorz

Aurora Cannabis Inc. says it is entering the U.S. market by acquiring hemp-based cannabidiol company Reliva LLC.

Edmonton-based Aurora will acquire all of the issued and outstanding membership interests of Reliva, while Reliva members will receive roughly US$40 million in Aurora’s common shares.

If Reliva achieves certain financial targets, the transaction includes a potential earn-out of up to a maximum US$45 million payable in Aurora shares, cash or a combination over the next two years.

Financial news and insights delivered to your email every Saturday.

The transaction is subject to closing conditions, but is expected to be complete by June.

Aurora says it was attracted to Reliva because of its management team’s experience selling and marketing regulated consumer packaged goods, its relationships with critical trade partners that provide a U.S. national distribution footprint and its financial discipline.

Story continues below advertisement

The deal comes months after Aurora embarked on a restructuring plan that involved taking $1 billion in writedowns and laying off 500 employees.